Stay updated on Neratinib for Metastatic Prostate Cancer Clinical Trial

Sign up to get notified when there's something new on the Neratinib for Metastatic Prostate Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Neratinib for Metastatic Prostate Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    A new revision entry v3.3.4 was added to the history and the v3.3.3 entry was removed; no study data or statuses appear to change.
    Difference
    0.1%
    Check dated 2026-01-14T02:14:39.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    30 days ago
    Change Detected
    Summary
    A new revision entry Revision: v3.3.3 was added to the record history; HHS Vulnerability Disclosure and Revision: v3.3.2 were removed.
    Difference
    0.2%
    Check dated 2025-12-23T13:46:59.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    A new revision entry v3.3.2 was added to the Record History, and the previous revision v3.3.1 was removed.
    Difference
    0.1%
    Check dated 2025-12-01T17:44:32.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Difference
    0.1%
    Check dated 2025-11-24T14:52:03.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    The government funding operating-status notice on the page has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.7%
    Check dated 2025-11-17T06:56:49.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    Record History shows updates to Recruitment Status and Study Status across multiple versions, reflecting how the trial's current state has evolved over time.
    Difference
    0.1%
    Check dated 2025-11-03T01:21:41.000Z thumbnail image

Stay in the know with updates to Neratinib for Metastatic Prostate Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Neratinib for Metastatic Prostate Cancer Clinical Trial page.